Author: ylin3

The CCHI IOFM Core funded nine applications submitted in response to our RFA released August 31, 2022. The CCHI Steering Committee sought applications from CCHI centers to capitalize on emerging opportunities and encourage multi-center, multi-disciplinary collaborations. The immediate objective of the CCHI is to support mechanistic and hypothesis-testing studies to understand human immunity applicable to the biodefense effort (i.e. innate, adaptive and mucosal immune responses to infection). Studies on immune-mediated diseases (e.g. airway allergy, food allergy, autoimmunity, organ transplant rejection) and basic human immunology are also of interest, as these data will provide a more comprehensive understanding of the human immune system. 

See the list of awardees below:

The CCHI IOFM Core funded seven applications submitted in response to our RFA released September 2, 2021. The CCHI Steering Committee sought applications from CCHI centers to capitalize on emerging opportunities and encourage multi-center, multi-disciplinary collaborations. The immediate objective of the CCHI is to support mechanistic and hypothesis-testing studies to understand human immunity applicable to the biodefense effort (i.e. innate, adaptive and mucosal immune responses to infection). Studies on immune-mediated diseases (e.g. airway allergy, food allergy, autoimmunity, organ transplant rejection) and basic human immunology are also of interest, as these data will provide a more comprehensive understanding of the human immune system. 

See the list of awardees below: